文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

纳米银氟化物对乳牙龋活跃性的抗菌效果:一项随机对照临床试验方案

The antibacterial effect of nanosilver fluoride in relation to caries activity in primary teeth: a protocol for a randomized controlled clinical trial.
PubMed 文献 · Trials · 2022-07-08

该方案拟纳入50名4至6岁、按ICDAS II标准评分为5分的活跃性牙本质龋患儿,随机等分为纳米银氟化物(NSF)组和氟化二胺银(SDF)对照组,在基线、1个月和3个月时采集龋损部位及非刺激性唾液样本,用选择性培养基计数变形链球菌和乳杆菌,并评估龋损静止情况与dmf指数。

要点

  • 拟纳入4至6岁活跃性牙本质龋(ICDAS II评分5分)儿童50名,随机等分为NSF组与SDF组。
  • 在基线、1个月和3个月采集龋损及非刺激性唾液样本,用Mitis Salivarius琼脂和Rogosa琼脂计数细菌,结果以菌落形成单位表示。
  • 按ICDAS II标准评估活跃龋损是否静止,并记录dmf指数;该试验已于2022年1月在ClinicalTrials.gov注册,编号NCT05221749。

核心结论

  • 方案拟评估NSF对牙本质龋损活跃性的抗菌效果,并比较其与SDF在1个月和3个月后唾液细菌水平的变化。

研究设计与样本

  • 随机对照临床试验方案,拟纳入50名4至6岁、按ICDAS II标准评分为5分的活跃性牙本质龋患儿,随机等分为NSF组和SDF对照组。

主要发现

  • 将评估两组细菌菌落计数与龋损活跃性的关系,以及唾液细菌计数的变化;收集的数据将进行统计学评价并制表。

关键数值与推荐

  • 龋损活跃性按ICDAS II标准评估,入组标准为ICDAS II评分5分的活跃性牙本质龋。
  • 细菌计数使用Mitis Salivarius琼脂(变形链球菌选择性培养基)和Rogosa琼脂(乳杆菌选择性培养基),结果以菌落形成单位表示。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive dentistry is a highly convenient and efficient method of managing caries in pediatric patients. Silver diamine fluoride (SDF) is commonly used to arrest active caries lesions. However, the associated black stain, possibility of soft tissue injury, and unpleasant taste often limit its use. Recently, nanosilver fluoride (NSF) emerged as a promising topical fluoride agent with potent cariostatic and antibacterial potentials. This novel anticaries agent has gained attention as an alternative to overcome the drawbacks of SDF in caries arrest. OBJECTIVES: To assess the antibacterial effect of NSF in relation to caries activity in dentin caries lesions, as well as to investigate the change in saliva bacterial levels in primary teeth in comparison to SDF after 1 and 3 months. MATERIALS AND METHODS: Fifty children aged 4 to 6 years old with active dentin caries lesions (score 5 according to International Detection and Assessment System (ICDAS II) criteria) will be enrolled in the study. They will be equally and randomly allocated into 2 groups: a group receiving NSF and a control group receiving SDF treatment. Microbiological samples will be collected from the carious lesions and from unstimulated saliva at the baseline and at the 1 and 3 months' follow-up appointments. Bacterial counts will be assessed using Mitis Salivarius agar (selective culture media for S. mutans) and Rogosa agar (selective culture media for lactobacilli), and the results will be expressed in colony-forming units. Data regarding the children's oral health will be collected and their dmf index will be scored. The arrest of active carious lesions will be measured at the follow-up appointments according to ICDAS II criteria. RESULTS: The relation between bacterial colony counts and lesion activity for both groups will be assessed, as well as the change in salivary bacterial counts. The collected data will be statistically evaluated and tabulated. This clinical trial has been registered on ClinicalTrials.gov in January 2022 (original version) with ID: NCT05221749.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ammar N, El-Tekeya MM, Essa S, et al. The antibacterial effect of nanosilver fluoride in relation to caries activity in primary teeth: a protocol for a randomized controlled clinical trial. Trials. 2022. PMID: 35804457. doi:10.1186/s13063-022-06477-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。